Henry Schein [HSIC] vs Cardinal Health [CAH] Detailed Stock Comparison
Henry Schein
NASDAQ
Loading...
Cardinal Health
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Henry Schein wins in 9 metrics, Cardinal Health wins in 10 metrics, with 0 ties. Cardinal Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Henry Schein | Cardinal Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 21.79 | 23.20 | Henry Schein |
| Price-to-Book Ratio | 2.40 | -13.52 | Cardinal Health |
| Debt-to-Equity Ratio | 68.55 | -3.56 | Cardinal Health |
| PEG Ratio | -1.77 | 4.45 | Henry Schein |
| EV/EBITDA | 12.42 | 12.65 | Henry Schein |
| Profit Margin (TTM) | 3.05% | 0.70% | Henry Schein |
| Operating Margin (TTM) | 5.40% | 1.05% | Henry Schein |
| EBITDA Margin (TTM) | 5.40% | 1.05% | Henry Schein |
| Return on Equity | 8.12% | -59.26% | Henry Schein |
| Return on Assets (TTM) | 4.54% | 3.16% | Henry Schein |
| Free Cash Flow (TTM) | $661.00M | $1.85B | Cardinal Health |
| Dividend Yield | N/A | 1.23% | N/A |
| 1-Year Return | -3.69% | 38.50% | Cardinal Health |
| Price-to-Sales Ratio (TTM) | 0.64 | 0.16 | Cardinal Health |
| Enterprise Value | $12.89B | $41.39B | Cardinal Health |
| EV/Revenue Ratio | 1.01 | 0.19 | Cardinal Health |
| Gross Profit Margin (TTM) | 31.36% | 3.66% | Henry Schein |
| Revenue per Share (TTM) | $103 | $924 | Cardinal Health |
| Earnings per Share (Diluted) | $3.11 | $6.45 | Cardinal Health |
| Beta (Stock Volatility) | 0.82 | 0.68 | Cardinal Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Henry Schein vs Cardinal Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Henry Schein | -0.63% | 0.44% | -1.25% | -5.37% | -11.69% | -0.50% |
| Cardinal Health | -2.36% | 0.90% | -4.42% | -1.13% | 19.29% | 28.43% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Henry Schein | -3.69% | -7.06% | 2.66% | 24.77% | 227.30% | 329.80% |
| Cardinal Health | 38.50% | 124.22% | 200.14% | 81.76% | 391.79% | 161.82% |
Performance & Financial Health Analysis: Henry Schein vs Cardinal Health
| Metric | HSIC | CAH |
|---|---|---|
| Market Information | ||
| Market Cap | $8.22B | $35.73B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 2,292,793 | 3,031,100 |
| 90 Day Avg. Volume | 1,958,574 | 2,151,357 |
| Last Close | $68.21 | $147.99 |
| 52 Week Range | $60.56 - $82.49 | $106.54 - $168.44 |
| % from 52W High | -17.31% | -12.14% |
| All-Time High | $92.68 (Apr 11, 2022) | $168.44 (Jul 01, 2025) |
| % from All-Time High | -26.40% | -12.14% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.03% | 0.01% |
| Quarterly Earnings Growth | -0.17% | 0.02% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | 0.01% |
| Operating Margin (TTM) | 0.05% | 0.01% |
| Return on Equity (TTM) | 0.08% | -0.59% |
| Debt to Equity (MRQ) | 68.55 | -3.56 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $28.26 | $-11.64 |
| Cash per Share (MRQ) | $1.20 | $16.22 |
| Operating Cash Flow (TTM) | $512.00M | $2.40B |
| Levered Free Cash Flow (TTM) | $358.25M | $2.07B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.23% |
| Last 12-Month Dividend | N/A | $2.04 |
Valuation & Enterprise Metrics Analysis: Henry Schein vs Cardinal Health
| Metric | HSIC | CAH |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 21.79 | 23.20 |
| Forward P/E | 13.03 | 17.32 |
| PEG Ratio | -1.77 | 4.45 |
| Price to Sales (TTM) | 0.64 | 0.16 |
| Price to Book (MRQ) | 2.40 | -13.52 |
| Market Capitalization | ||
| Market Capitalization | $8.22B | $35.73B |
| Enterprise Value | $12.89B | $41.39B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.01 | 0.19 |
| Enterprise to EBITDA | 12.42 | 12.65 |
| Risk & Other Metrics | ||
| Beta | 0.82 | 0.68 |
| Book Value per Share (MRQ) | $28.26 | $-11.64 |
Financial Statements Comparison: Henry Schein vs Cardinal Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | HSIC | CAH |
|---|---|---|
| Revenue/Sales | $3.17B | $60.16B |
| Cost of Goods Sold | $2.17B | $57.96B |
| Gross Profit | $1.00B | $2.20B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $200.00M | $585.00M |
| EBITDA | $278.00M | $824.00M |
| Pre-Tax Income | $145.00M | $384.00M |
| Income Tax | $35.00M | $141.00M |
| Net Income (Profit) | $113.00M | $243.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | HSIC | CAH |
|---|---|---|
| Cash & Equivalents | $127.00M | $3.87B |
| Total Current Assets | $4.04B | $36.37B |
| Total Current Liabilities | $2.92B | $38.90B |
| Long-Term Debt | $2.22B | $7.98B |
| Total Shareholders Equity | $4.72B | $-2.63B |
| Retained Earnings | $3.63B | $783.00M |
| Property, Plant & Equipment | $850.00M | $2.18B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | HSIC | CAH |
|---|---|---|
| Operating Cash Flow | $147.00M | $1.31B |
| Capital Expenditures | $-31.00M | $-235.00M |
| Free Cash Flow | $-6.00M | $1.30B |
| Debt Repayment | $-15.00M | $-11.00M |
| Common Stock Repurchase | $-161.00M | $0 |
Short Interest & Institutional Ownership Analysis
| Metric | HSIC | CAH |
|---|---|---|
| Shares Short | 7.78M | 5.58M |
| Short Ratio | 4.75 | 2.97 |
| Short % of Float | 0.07% | 0.03% |
| Average Daily Volume (10 Day) | 2,292,793 | 3,031,100 |
| Average Daily Volume (90 Day) | 1,958,574 | 2,151,357 |
| Shares Outstanding | 124.16M | 238.68M |
| Float Shares | 103.82M | 238.14M |
| % Held by Insiders | 0.01% | 0.00% |
| % Held by Institutions | 1.14% | 0.89% |
Dividend Analysis & Yield Comparison: Henry Schein vs Cardinal Health
| Metric | HSIC | CAH |
|---|---|---|
| Last 12-Month Dividend | N/A | $2.04 |
| Last 12-Month Dividend Yield | N/A | 1.23% |
| 3-Year Avg Annual Dividend | N/A | $2.01 |
| 3-Year Avg Dividend Yield | N/A | 0.56% |
| 3-Year Total Dividends | N/A | $6.04 |
| Ex-Dividend Date | N/A | Apr 01, 2025 |